Get started
JOHNSON & JOHNSONJOHNSON & JOHNSONJOHNSON & JOHNSON

JOHNSON & JOHNSON

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Bonds

JNJ trade ideas

JNJ 1.272 Fib Ext Target IdentifiedJNJ which is a component of the DOW is scanning on A6 with a short squeeze setup. Using Fib extension 1.272 target, a price target has been identified to be approx $175. This extension was developed using the March 4th and 29th lows and highs, respectively. A6 scanning implies there is news being priced in and perhaps JNJ may announce or report new drug studies that could ignite the price to push toward the 2.618 fib ext which is $186. If this is the case, then JNJ may as well run toward a psych tgt of $200 sometime within the next 14 to 34 trading days.
NYSE:JNJ
by TOSOPTION
JOHNSON & JOHNSON (JNJ)In my work, I always try to combine fundamental analysis and technical analysis. They are both important, especially on a topic as important as the covid vaccine. Johnson & Johnson is about to be marketed, after the approval of the EMA on 11 March. Exactly after the announcement, I bought the stock. The JnJ vaccine has a much lower distribution cost than Pfizer since it can be stored at refrigerator temperatures, like AstraZeneca. The difference is in the prestige and history that the company has. Moreover, the share according to the average of analysts, still has ample room for growth, with an average target of $ 185 and a second "high" at $ 200. Technically speaking, the price bounced off the bullish support trendline on Thursday, March 4th, and then broke the resistance trendline on the 12th, exactly the day after the announcement of the EMA's approval. The trend is clearly bullish, but, even keeping in mind the analysts' opinion, I believe the first target in area 170 is more likely. If everything goes well with the vaccine, the analyst targets could be greatly raised. It is a different trade, to be constantly monitored with a trailing stop, in case there will be any hitches or cases of a block, as happened for AstraZeneca. Such an open market scenario would cause a crash, so you have to be ready to get out quickly. Lazy Bull 1st target: 170 2nd target: 180 3rd target: 200 DISCLAIMER: I am not a financial advisor nor a CPA. These posts, videos, and any other contents are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.
NYSE:JNJLong
by LazyBull5
2
$JNJ has baby fetus' in their vaccine - look it up$JNJ Said they don't have any evidence that the blood clots are related to the vaccine. That's like saying Hunter Biden doesn't smoke crack. Anyway, even though JNJ has alot of bad news surrounding them, it looks like it's forming an Ascending triangle. I am looking to play the ER runup. ER is on 4/20. Last earnings it ran up the day before and day of earnings. I don't think that it will run on both days due to uncertainty. I have currently have 1 $162.5c. My PT is $164-165. 4HR MACD curling up!
NYSE:JNJLong
by DarthTrador
JNJ- POSSIBLE PUT OPTIONS - MAY 21ST 0.84 CONTRACTS $150All, In semi recent news it's very possible JNJ loses the COVID contracts or at least long enough to take a solid tumble. IF it breaks into the red zone it should trigger a loss of a high and break trend downwards again to $145-$132 level. As always wait for conformation of breaking under first level and watch options volume/contracts for changes in price and news. JNJ in a prime spot to be shorted. Also you can always cover with calls.
NYSE:JNJShort
by DigitalData
3